| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.24▼ | 5.25▼ | 5.25▼ | 5.73▼ | 6.42▼ |
| MA10 | 5.30▼ | 5.51▼ | 5.51▼ | 6.20▼ | 5.90▼ |
| MA20 | 5.66▼ | 6.13▼ | 6.13▼ | 6.44▼ | 6.59▼ |
| MA50 | 6.21▼ | 6.82▼ | 6.96▼ | 5.99▼ | 11.95▼ |
| MA100 | 7.35▼ | 6.30▼ | 6.36▼ | 6.47▼ | 35.98▼ |
| MA200 | 6.92▼ | 7.72▼ | 7.37▼ | 8.20▼ | 865.62▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.008▼ | -0.077▼ | -0.082▼ | -0.189▼ | 0.659▲ |
| RSI | 32.796▼ | 34.792▼ | 34.805▼ | 37.614▼ | 40.978▼ |
| STOCH | 6.654▼ | 5.716▼ | 5.716▼ | 14.103▼ | 29.219 |
| WILL %R | -97.297▼ | -98.710▼ | -98.710▼ | -94.167▼ | -90.791▼ |
| CCI | -58.333 | -82.860 | -82.860 | -148.980▼ | -54.530 |
|
Wednesday, September 02, 2026 07:02 AM
Wednesday, SciSparc Ltd. ( SPRC) announced that its subsidiary, NeuroThera Labs Inc. ( NTLX.V) is pursuing U.S. Food and Drug Administration's Orphan Drug Designation covering SCI-110, which combines ...
|
|
Wednesday, September 02, 2026 05:17 AM
This strategic engagement is designed to strengthen NeuroThera’s U.S. market position, visibility among key U.S. federal stakeholders, reinforce the clinical and public‑health importance of advancing ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/09/26 | 5.17 | 5.435 | 5.15 | 5.29 | 27,700 |
| 03/09/26 | 5.36 | 5.36 | 5.20 | 5.20 | 39,395 |
| 02/09/26 | 5.80 | 6.00 | 5.41 | 5.85 | 49,300 |
| 01/09/26 | 6.062 | 6.22 | 5.50 | 5.67 | 89,309 |
| 31/08/26 | 6.68 | 6.88 | 6.55 | 6.63 | 61,810 |
| 28/08/26 | 6.75 | 6.75 | 6.50 | 6.58 | 84,130 |
| 27/08/26 | 6.55 | 6.775 | 6.54 | 6.62 | 11,356 |
| 26/08/26 | 6.665 | 7.19 | 6.6001 | 6.74 | 13,875 |
| 25/08/26 | 6.62 | 6.855 | 6.61 | 6.69 | 7,115 |
| 21/08/26 | 6.50 | 6.695 | 6.50 | 6.695 | 2,477 |
|
|
||||
|
|
||||
|
|